Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Summary
Vericel announced that it will present at the 2026 Truist Securities MedTech Conference on June 16, 2026. The company positions itself as a provider of advanced therapies for sports medicine and severe burn care. Its portfolio includes MACI, Epicel, and an exclusive North American license for NexoBrid. The announcement mainly serves investor communications and does not describe a new product, transaction, or leadership change.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected